PL361300A1 - N-(3,5-dichloro-2-metoksyfenylo)-4-metoksy-3-piperazyn-1-ylo-benzenosulfonamid - Google Patents

N-(3,5-dichloro-2-metoksyfenylo)-4-metoksy-3-piperazyn-1-ylo-benzenosulfonamid

Info

Publication number
PL361300A1
PL361300A1 PL36130001A PL36130001A PL361300A1 PL 361300 A1 PL361300 A1 PL 361300A1 PL 36130001 A PL36130001 A PL 36130001A PL 36130001 A PL36130001 A PL 36130001A PL 361300 A1 PL361300 A1 PL 361300A1
Authority
PL
Poland
Prior art keywords
benzenesulfonamide
piperazin
methoxyphenyl
dichloro
methoxy
Prior art date
Application number
PL36130001A
Other languages
English (en)
Inventor
Steven Mark Bromidge
Stephen Frederick Moss
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of PL361300A1 publication Critical patent/PL361300A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL36130001A 2000-08-31 2001-08-27 N-(3,5-dichloro-2-metoksyfenylo)-4-metoksy-3-piperazyn-1-ylo-benzenosulfonamid PL361300A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021450.2A GB0021450D0 (en) 2000-08-31 2000-08-31 Novel compounds
PCT/EP2001/009927 WO2002018358A1 (en) 2000-08-31 2001-08-27 N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide

Publications (1)

Publication Number Publication Date
PL361300A1 true PL361300A1 (pl) 2004-10-04

Family

ID=9898634

Family Applications (1)

Application Number Title Priority Date Filing Date
PL36130001A PL361300A1 (pl) 2000-08-31 2001-08-27 N-(3,5-dichloro-2-metoksyfenylo)-4-metoksy-3-piperazyn-1-ylo-benzenosulfonamid

Country Status (16)

Country Link
US (1) US20040034036A1 (pl)
EP (1) EP1313720A1 (pl)
JP (1) JP2004507530A (pl)
KR (1) KR20030024919A (pl)
CN (1) CN1449391A (pl)
AU (1) AU2001284041A1 (pl)
BR (1) BR0113650A (pl)
CA (1) CA2420935A1 (pl)
CZ (1) CZ2003579A3 (pl)
GB (1) GB0021450D0 (pl)
HU (1) HUP0300863A2 (pl)
IL (1) IL154675A0 (pl)
MX (1) MXPA03001783A (pl)
NO (1) NO20030868L (pl)
PL (1) PL361300A1 (pl)
WO (1) WO2002018358A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0204720D0 (en) * 2002-02-28 2002-04-17 Glaxo Group Ltd Novel use
RU2309154C9 (ru) * 2002-03-27 2016-09-27 Глэксо Груп Лимитед 3-фенилсульфонил-8-пиперазин-1-ил-хинолины, обладающие аффинностью к 5-нт6 рецептору, способы их получения (варианты)
DE602004000260T2 (de) 2003-07-22 2006-08-24 Arena Pharmaceuticals, Inc., San Diego Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
EP1976495A2 (en) * 2006-01-06 2008-10-08 Aarhus Universitet Compounds acting on the serotonin transporter
US20100041672A1 (en) * 2007-03-21 2010-02-18 Glaxo Group Limited Use of quinoline derivatives in the treatment of pain and irritable bowel syndrome
EP2508177A1 (en) 2007-12-12 2012-10-10 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
US20110021538A1 (en) 2008-04-02 2011-01-27 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
US9126946B2 (en) 2008-10-28 2015-09-08 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
US9840482B2 (en) 2014-04-19 2017-12-12 Sunshine Lake Pharma Co., Ltd. Sulfonamide derivatives and pharmaceutical applications thereof
US10022355B2 (en) 2015-06-12 2018-07-17 Axovant Sciences Gmbh Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder
BR112018000728A2 (pt) 2015-07-15 2018-09-04 Axovant Sciences Gmbh resumo método para a profilaxia e/ou tratamento de alucinações visuais em um sujeito com necessidade do mesmo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0994862B1 (en) * 1997-07-11 2005-06-01 SmithKline Beecham plc Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation
GB9803411D0 (en) * 1998-02-18 1998-04-15 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
MXPA03001783A (es) 2003-06-04
CN1449391A (zh) 2003-10-15
EP1313720A1 (en) 2003-05-28
CA2420935A1 (en) 2002-03-07
HUP0300863A2 (hu) 2003-09-29
JP2004507530A (ja) 2004-03-11
BR0113650A (pt) 2004-02-10
US20040034036A1 (en) 2004-02-19
KR20030024919A (ko) 2003-03-26
CZ2003579A3 (cs) 2003-09-17
IL154675A0 (en) 2003-09-17
WO2002018358A1 (en) 2002-03-07
NO20030868D0 (no) 2003-02-25
AU2001284041A1 (en) 2002-03-13
GB0021450D0 (en) 2000-10-18
NO20030868L (no) 2003-04-04

Similar Documents

Publication Publication Date Title
TW539393U (en) 089204149
ZA200205479B (en) Novel biarylcarboxamides.
TW595857U (en) 091219345
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
MXPA02001088A (es) 2-pirazolin-5-onas..
IL165436A0 (en) 7,10-bis-trichlotoacetyl-10 deactylbaccatin III
GB0206191D0 (en) None available at present time
MXPA03001991A (es) Novedosas arilalcano-sulfonamidas.
IL154675A0 (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
IL162310A0 (en) 3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
MXPA01011743A (es) Arilpirimidinas substituidas 5-.
EG23084A (en) Optically active 2,5-bisaryl-delta1-pyrrolines
GB2355714B (en) Ammonium 3,5-diaminopicrate
GB0028849D0 (en) Improved keysheath
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
AU3040102A (en) Insecticidal 1,8-naphthalenedicarboxamides
GB0104243D0 (en) Floodstoppers 2
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
GB0004254D0 (en) Improved capodastro
GB0007203D0 (en) Supertrowel 2000
GB2364426B (en) Improved capodastro
PL371851A1 (pl) Pochodne 3,4-dihydro-1-H-izochinolin-2-ylu
GB0017600D0 (en) B,jc 2000
GB0020760D0 (en) W.I.Type 1
GB0023161D0 (en) Sepo 7

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)